AbbVie Deutschland GmbH & Co. KG

The sponsor maintains a comprehensive research portfolio addressing immune-mediated conditions affecting multiple organ systems. Investigation encompasses rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, exploring various therapeutic interventions including JAK inhibitors and TNF-alpha inhibitors. Research extends to inflammatory bowel diseases, specifically Crohn's disease and ulcerative colitis, examining both induction and maintenance treatment strategies.

• Rheumatic and Musculoskeletal Diseases
• Dermatological Immune Conditions
• Gastrointestinal Inflammatory Pathologies
• Systemic Autoimmune Disorders

Studies evaluate disease activity measures, structural damage progression, and patient-reported outcomes across diverse populations, including treatment-naïve patients and those with inadequate responses to conventional therapies. The research incorporates radiographic progression assessment and biomarker analysis to understand therapeutic mechanisms.